share_log

今日大行评级 | 奈飞获KeyBanc看高至1000美元,瑞穗证券削Elevance Health目标价至455美元

Today's Analyst Rating | Netflix Price Target Raised to $1000 by KeyBanc, Mizuho Securities Cuts Its Price Target Cut on Elevance Health to $455

Futu News ·  05:00  · Ratings

Dec 24, Wall Street analysts have updated their stock ratings today including $Netflix (NFLX.US)$ and $Elevance Health (ELV.US)$.

Upgrades:

KeyBanc analyst Justin Patterson maintains $Netflix (NFLX.US)$ with buy rating, and adjust the target price from USD785 to USD1000.

Loop Capital analyst Mark Schappel maintains $Snowflake (SNOW.US)$ with buy rating, and adjust the target price from USD185 to USD205.

Loop Capital analyst Yun Kim maintains $Datadog (DDOG.US)$ with buy rating, and adjust the target price from USD160 to USD200.

Downgrades:

Mizuho Securities analyst Ann Hynes maintains $Elevance Health (ELV.US)$ with buy rating, and adjust the target price from USD505 to USD455.

Mizuho Securities analyst John Baumgartner maintains $The Kraft Heinz (KHC.US)$ with buy rating, and adjust the target price from USD41 to USD38.

UBS analyst Tasso Vasconcellos maintains $Ecopetrol (EC.US)$ with hold rating, and adjust the target price from USD11 to USD8.

For more trending U.S. stock ratings today, refer to the chart below:

USTodayAnalystRatingAutoNewsSpider_nn_20241224_1735045201_en-us

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment